Biopharmaceutical News and Research

RSS

Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry today announced the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics.

From Sartorius 9 May 2019

Sartorius Stedim Biotech introduces new ambr 15 cell culture microbioreactor system

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, is introducing its new generation of ambr 15 cell culture automated microbioreactor system.

From Sartorius 3 May 2019

Mulvaney: Trump brought down drug prices for the first time in 50 years

President Donald Trump announced last month that the GOP will become “the party of health care,” and news reports suggest he intends to make it a top issue in his reelection campaign.

15 Apr 2019

Bruker highlights innovative NMR capabilities and products at ENC 2019

At ENC 2019, Bruker highlights innovative NMR capabilities and products for biomolecular, materials research and pharmaceutical applications, as well as new scientific software solutions.

From Bruker BioSpin Division 10 Apr 2019

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019

New clinical trials to investigate combination immunotherapy for treating advanced cancers

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly-impossible-to-treat cancer into a disease that can be corralled into remission.

8 Apr 2019

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

On April 8, Celltrion and the Canada-based iProgen Biotech Inc. announced to agree to partner for the development of novel ADCs against validated antibody targets, including HER2 and CD20.

8 Apr 2019

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

4 Apr 2019

Study provides framework for developing Ebola virus therapeutic under FDA Animal Rule

The U.S. Army Medical Research Institute of Infectious Diseases today announced that, for the first time, the U.S. Food and Drug Administration has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus infections.

29 Mar 2019

Sartorius wins double award at Fisher Scientific European Sales Conference for the second time

Sartorius was once again a double award winner at the Fisher Scientific European Sales Conference in Karpacz, Poland.

From Sartorius 25 Mar 2019

FDA approves brexanolone, first drug developed to treat postpartum depression

Approximately 1 in 9 women in the United States experiences symptoms of postpartum depression, according to the Centers for Disease Control and Prevention.

21 Mar 2019

First postpartum depression drug gets FDA nod

Sage therapeutics’ Zulresso became the first drug approved for postpartum depression by the United States Food and Drugs Administration (FDA). This cause the shares of Sage to rise by over 5 percent on Tuesday this week.

20 Mar 2019

Pall Corporation expands collaboration agreement with ARTeSYN Biosolutions

Pall Corporation, a global leader in filtration, separation and purification, announced the next step in the collaboration agreement with ARTeSYN Biosolutions, a leading innovator in single-use components and fluid management technologies.

From Pall Corporation 14 Mar 2019

Parkinson's disease: Servier and Oncodesign announce research and drug development partnership

Servier and Oncodesign have announced a strategic partnership for the research and development of potential drug candidates for Parkinson's disease.

12 Mar 2019

ACROBiosystems opens new Innovation laboratory in Delaware

January 18, 2018, ACROBiosystems officially opened its New Innovation laboratory in the Delaware Innovation Space in Wilmington, Delaware, USA, and held a grand opening ceremony.

From ACROBiosystems 7 Mar 2019

SSB and Novasep collaborate to develop new membrane chromatography systems

Sartorius Stedim Biotech, a leading supplier for the biopharmaceutical industry, and Novasep based in Pompey, France, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing.

From Sartorius 6 Mar 2019

FutureNeuro collaborates with UCB to inform improvements in epilepsy treatment

FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI, has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy.

5 Mar 2019

Translucent wonder material used on stadium roofs helps measure protein particles

Understanding how proteins clump together is essential in modern pharmaceuticals. When these tiny particles aggregate, they can alter the effectiveness of both vaccines and drugs, especially many of the new, popular formulations derived from monoclonal antibodies.

1 Mar 2019

Sartorius successfully closes fiscal year 2018 and plans to continuously expand

Sartorius, a leading international partner of biopharmaceutical research and the industry, confirmed its preliminary figures with the publication of its 2018 Annual Report.

From Sartorius 21 Feb 2019

Machine learning algorithm could accelerate the search for new drugs

Researchers have designed a machine learning algorithm for drug discovery which has been shown to be twice as efficient as the industry standard, which could accelerate the process of developing new treatments for disease.

12 Feb 2019